Cwm LLC Sells 1,753 Shares of Alignment Healthcare, Inc. $ALHC

Cwm LLC cut its position in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 16.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,800 shares of the company’s stock after selling 1,753 shares during the quarter. Cwm LLC’s holdings in Alignment Healthcare were worth $123,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. Blue Trust Inc. raised its stake in shares of Alignment Healthcare by 48.4% in the second quarter. Blue Trust Inc. now owns 36,912 shares of the company’s stock valued at $517,000 after buying an additional 12,045 shares during the period. KLP Kapitalforvaltning AS raised its position in shares of Alignment Healthcare by 39.5% in the second quarter. KLP Kapitalforvaltning AS now owns 24,000 shares of the company’s stock valued at $336,000 after purchasing an additional 6,800 shares during the period. LGT Fund Management Co Ltd. bought a new stake in shares of Alignment Healthcare in the second quarter valued at approximately $2,121,000. 111 Capital bought a new stake in shares of Alignment Healthcare in the second quarter valued at approximately $325,000. Finally, Hennessy Advisors Inc. bought a new stake in shares of Alignment Healthcare in the second quarter valued at approximately $7,853,000. 86.19% of the stock is currently owned by institutional investors.

Insider Transactions at Alignment Healthcare

In other news, President Dawn Christine Maroney sold 215,662 shares of the company’s stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $3,539,013.42. Following the completion of the transaction, the president directly owned 1,797,237 shares in the company, valued at approximately $29,492,659.17. This represents a 10.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Hyong Kim sold 51,379 shares of the business’s stock in a transaction dated Thursday, October 9th. The shares were sold at an average price of $17.57, for a total value of $902,729.03. Following the completion of the sale, the insider directly owned 362,333 shares of the company’s stock, valued at approximately $6,366,190.81. This trade represents a 12.42% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 7,427,716 shares of company stock worth $119,650,069. Company insiders own 7.00% of the company’s stock.

Wall Street Analysts Forecast Growth

ALHC has been the topic of several research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, October 8th. Barclays set a $18.00 price target on Alignment Healthcare in a research report on Friday. Wall Street Zen cut Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, August 10th. KeyCorp upgraded Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target for the company in a research report on Monday, August 25th. Finally, The Goldman Sachs Group started coverage on Alignment Healthcare in a research report on Tuesday, October 14th. They issued a “buy” rating and a $21.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $19.65.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $16.86 on Friday. The company’s fifty day moving average price is $16.88 and its 200-day moving average price is $15.53. The firm has a market capitalization of $3.34 billion, a price-to-earnings ratio of -140.50 and a beta of 1.18. Alignment Healthcare, Inc. has a one year low of $10.18 and a one year high of $21.06. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 17.79%. The firm had revenue of $993.70 million for the quarter, compared to analyst estimates of $980.90 million. During the same quarter in the prior year, the firm earned ($0.14) EPS. The business’s revenue for the quarter was up 43.5% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, equities research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.